12 documents found, page 1 of 2

The International System for Reporting Serous Fluid Cytopathology

Publisher Copyright: © 2021 by the authors.; Serous effusion cytology is widely employed in the initial evaluation of the etiology of effusions with a high diagnostic sensitivity. To standardize practices, The International System for Reporting Serous Fluid Cytology (TIS) was developed following best international practices, the most up-to-date literature, and expert consensus. In the context of this system, an...

Cytohistological correlation in pleural effusions based on the international sy...

The International System for Reporting Serous Fluid Cytology (TIS) was recently developed. Given its novelty, most studies looking into the risk of malignancy (ROM) of serous effusion diagnostic categories were published before the development of TIS. We searched the database of our department for pleural effusions diagnosed in the last five years, excluding those without a corresponding pleural biopsy. Cases w...

How the COVID-19 Pandemic Impacted Oncological Molecular Diagnosis

Introduction: The Portuguese healthcare system had to adapt at short notice to the COVID-19 pandemic. We implemented workflow changes to our molecular pathology laboratory, a national reference center, to maximize safety and productivity. We assess the impact this situation had on our caseload and what conclusions can be drawn about the wider impact of the pandemic in oncological therapy in Portugal. Material a...

Initial Therapeutic Choices for Type 2 Diabetes in the Portuguese Sentinel Prac...

INTRODUCTION: Type 2 diabetes is a major driver of pharmaceutical spending. We aimed to determine the proportion of new patients who begin treatment with each antidiabetic medicine class, if therapy was initiated by their family physician, if family physicians alter prescriptions initiated by other physicians, and to compare prescribing patterns of family physicians and other specialists. MATERIAL AND METHODS: ...

Initial therapeutic choices for hypertension in the Portuguese Sentinel Practic...

Copyright © 2018 Sociedade Portuguesa de Cardiologia. Publicado por Elsevier España, S.L.U. All rights reserved.; INTRODUCTION AND OBJECTIVES: Finding out which drugs are chosen to treat incident cases of hypertension may help in interpreting prevalent use of antihypertensive agents. We aimed to determine the proportion of patients who begin treatment with each antihypertensive drug class, which physicians init...

Effectiveness of educational outreach visits compared with usual guideline diss...

Background: Educational outreach visits are meant to improve the practice of health professionals by promoting face-to-face visits to deliver educational contents. They have been shown to change prescription behavior, but long-term effects are still uncertain. This trial aimed to determine if they improve family physician prescribing compared with passive guideline dissemination. Methods: Parallel, open, superi...

Worldwide Usage of International Classification of Primary Care

A reference case for economic evaluations in osteoarthritis

Publisher Copyright: © 2014 The Authors.; Background: General recommendations for a reference case for economic studies in rheumatic diseases were published in 2002 in an initiative to improve the comparability of cost-effectiveness studies in the field. Since then, economic evaluations in osteoarthritis (OA) continue to show considerable heterogeneity in methodological approach. Objectives: To develop a refere...

An open cluster-randomized, 18-month trial to compare the effectiveness of educ...

Background: The Portuguese National Health Directorate has issued clinical practice guidelines on prescription of anti-inflammatory drugs, acid suppressive therapy, and antiplatelets. However, their effectiveness in changing actual practice is unknown. Methods: The study will compare the effectiveness of educational outreach visits regarding the improvement of compliance with clinical guidelines in primary care...

Health economics in the field of osteoarthritis

Funding Information: M.H. (Mickael Hiligsmann) has received research grant, lecture fees, and/or consulting fees from Amgen, Pfizer, Novartis, Servier, and SMB. C.C. has received honoraria and consulting fees from AMGEN, GSK, Alliance for Better Bone Health, MSD, Eli Lilly, Pfizer, Novartis, Servier, Medtronic, and Roche. M.-L.B. was consultant and grant recipient from Amgen, Eli Lilly, MSD, Novartis, NPS, Roch...